Back
Ultralife Corp. 10K Form
Sell
33
ULBI
Ultralife Corp.
Last Price:
$6.48
Seasonality Move:
5.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | ULBI/Ultralife Corp. Quarterly |
| 2023-10-26 | 10Q | ULBI/Ultralife Corp. Quarterly |
| 2023-07-27 | 10Q | ULBI/Ultralife Corp. Quarterly |
| 2023-05-04 | 10Q | ULBI/Ultralife Corp. Quarterly |
| 2022-10-27 | 10Q | ULBI/Ultralife Corp. Quarterly |
| 2022-07-28 | 10Q | ULBI/Ultralife Corp. Quarterly |
Receive ULBI News And Ratings
See the #1 stock for the next 7 days that we like better than ULBI
ULBI Financial Statistics
Sales & Book Value
| Annual Sales: | $191.2M |
|---|---|
| Cash Flow: | $-821K |
| Price / Cash Flow: | 9.88 |
| Annual Sales: | $8.24 |
| Price / Book: | 0.74 |
Profitability
| EPS (TTM): | -0.35440 |
|---|---|
| Net Income (TTM): | $-6M |
| Gross Margin: | $46M |
| Return on Equity: | -4.4% |
| Return on Assets: | -2.69% |
Ultralife Corp. Earnings Forecast
Key Ultralife Corp. Financial Ratios
-
The Gross Profit Margin over the past 34 years for ULBI is 24.07%.
-
The Selling, General & Administrative Expenses for ULBI have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 5.44% of Revenue.
-
The Net Earning history of ULBI is -3.11% of Total Revenues.
-
Per Share Earnings over the last 34 years have been positive in 19 years.
Ultralife Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Electrical Equipment |
| Sector: | Industrials |
| Current Symbol: | ULBI |
| CUSIP: | 903899 |
| Website: | ultralifecorporation.com |
Debt
| Debt-to-Equity Ratio: | 0.38 |
|---|---|
| Current Ratio: | 2.83 |
| Quick Ratio: | 1.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 14.15 |
|---|---|
| Forward P/E Ratio: | 7.66 |
ULBI Technical Analysis vs Fundamental Analysis
Sell
33
Ultralife Corp. (ULBI)
is a Sell
Is Ultralife Corp. a Buy or a Sell?
-
Ultralife Corp. stock is rated a SellThe current Ultralife Corp. [ULBI] share price is $5.88. The Score for ULBI is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.